Novare Capital Management LLC Zoetis Inc. Transaction History

Novare Capital Management LLC

$1.17 Billion
Q4 2024

A detailed history of Novare Capital Management LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Novare Capital Management LLC holds 47,003 shares of ZTS stock, worth $7.4 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

47,003

Previous 48,886 3.85%

Holding current value

$7.4 Million

Previous $9.55 Million 19.82%

% of portfolio

0.66%

Previous 0.82%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	SELL	$162.24 - $194.42 $305,497 - $366,092	-1,883 Reduced 3.85%	47,003 $7.66 Million
Q3 2024 Oct 11, 2024	SELL	$172.58 - $196.48 $172,580 - $196,480	-1,000 Reduced 2.0%	48,886 $9.55 Million
Q2 2024 Aug 01, 2024	BUY	$145.54 - $178.83 $68,258 - $83,871	469 Added 0.95%	49,886 $8.65 Million
Q1 2024 May 06, 2024	BUY	$165.67 - $199.94 $333,659 - $402,679	2,014 Added 4.25%	49,417 $8.36 Million
Q4 2023 Feb 08, 2024	BUY	$151.44 - $200.09 $322,567 - $426,191	2,130 Added 4.7%	47,403 $9.36 Million
Q3 2023 Nov 02, 2023	SELL	$167.14 - $192.77 $145,411 - $167,709	-870 Reduced 1.89%	45,273 $7.88 Million
Q2 2023 Jul 28, 2023	SELL	$160.94 - $186.23 $97,368 - $112,669	-605 Reduced 1.29%	46,143 $7.95 Million
Q1 2023 Apr 20, 2023	SELL	$145.48 - $175.02 $35,060 - $42,179	-241 Reduced 0.51%	46,748 $7.78 Million
Q4 2022 Jan 17, 2023	SELL	$131.14 - $157.47 $14,294 - $17,164	-109 Reduced 0.23%	46,989 $0
Q3 2022 Oct 11, 2022	BUY	$148.29 - $182.55 $148,883 - $183,280	1,004 Added 2.18%	47,098 $6.98 Million
Q2 2022 Aug 03, 2022	SELL	$155.97 - $200.09 $150,667 - $193,286	-966 Reduced 2.05%	46,094 $7.92 Million
Q1 2022 May 09, 2022	SELL	$181.39 - $234.03 $106,475 - $137,375	-587 Reduced 1.23%	47,060 $8.88 Million
Q4 2021 Feb 03, 2022	SELL	$193.69 - $247.03 $100,525 - $128,208	-519 Reduced 1.08%	47,647 $11.6 Million
Q3 2021 Nov 04, 2021	SELL	$189.29 - $209.69 $323,496 - $358,360	-1,709 Reduced 3.43%	48,166 $9.35 Million
Q2 2021 Aug 02, 2021	BUY	$155.9 - $187.99 $248,192 - $299,280	1,592 Added 3.3%	49,875 $9.3 Million
Q1 2021 May 11, 2021	SELL	$144.0 - $169.39 $5,040 - $5,928	-35 Reduced 0.07%	48,283 $7.6 Million
Q1 2021 May 07, 2021	BUY	$144.0 - $169.39 $615,600 - $724,142	4,275 Added 9.71%	48,318 $7.61 Million
Q4 2020 Feb 01, 2021	BUY	$157.07 - $174.35 $66,911 - $74,273	426 Added 0.98%	44,043 $7.29 Million
Q3 2020 Nov 03, 2020	BUY	$137.1 - $165.37 $262,272 - $316,352	1,913 Added 4.59%	43,617 $7.21 Million
Q2 2020 Aug 06, 2020	BUY	$111.92 - $142.53 $617,686 - $786,623	5,519 Added 15.25%	41,704 $5.72 Million
Q1 2020 May 05, 2020	BUY	$92.66 - $144.94 $3.35 Million - $5.24 Million	36,185 New	36,185 $4.26 Million

Others Institutions Holding ZTS

# of Institutions

2,031

Shares Held

416M

Call Options Held

1.23M

Put Options Held

1.3M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $73.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Novare Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Novare Capital Management LLC with notifications on news.

Account

Novare Capital Management LLC Zoetis Inc. Transaction History